help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cibula, D.
Right arrow Articles by Zivny, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cibula, D.
Right arrow Articles by Zivny, J.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 12 5821-5825
Copyright © 2002 by The Endocrine Society


Original Article

Prediction of Insulin Sensitivity in Nonobese Women with Polycystic Ovary Syndrome

D. Cibula, J. Skrha, M. Hill, M. Fanta, L. Haaková, J. VrbÍková and J. Zivny

Department of Obstetrics and Gynecology (D.C., M.F., L.H., J.Z.), Charles University, Praha 2, 120 00, Czech Republic; Department of Internal Medicine (J.S.), Charles University, Praha 2, 120 00, Czech Republic; and Institute of Endocrinology (M.H., J.V.), Prague, Praha 1, 100 00, Czech Republic

Address all correspondence and requests for reprints to: David Cibula, M.D., Ph.D., Department of Obstetrics and Gynecology, Charles University, Apolinárská 18, Praha 2, 120 00, Czech Republic. E-mail: david.cibula{at}iol.cz.

Abstract

Insulin resistance is a frequent (although not constant) abnormality in both obese and nonobese women with polycystic ovary syndrome (PCOS). It plays a key role in the predisposition to type 2 diabetes, which is the most important health consequence of the syndrome. Identification of patients with insulin resistance is significant both for follow-up and for therapeutic reasons. The aim of the study was to evaluate the relationships between insulin sensitivity, measured by euglycemic clamp, and both endocrine and metabolic indices and to identify the best model for predicting insulin sensitivity. A total of 41 nonobese women fulfilling the diagnostic criteria for PCOS were enrolled in the study. None of the androgens correlated with the insulin sensitivity index. All clamp parameters correlated with SHBG, triglycerides, and body mass index, although no correlation was found with waist to hip ratio or waist circumference. The close relationship between insulin sensitivity and SHBG was documented by factor analysis and by its presence in all prediction models as the most significant (or even the single) predictor of the insulin sensitivity index. In conclusion: 1) a decreased level of SHBG can be used as a single reliable parameter in the prediction of insulin sensitivity in nonobese women with PCOS; and 2) waist to hip ratio, waist circumference, and androgen concentrations have no predictive value.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller
Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome
Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. M. Miles and M. D. Jensen
Counterpoint: Visceral Adiposity Is Not Causally Related to Insulin Resistance
Diabetes Care, September 1, 2005; 28(9): 2326 - 2328.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. M. Adams, A. E. Taylor, W. F. Crowley Jr., and J. E. Hall
Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4343 - 4350.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. Ganie, M. L. Khurana, M. Eunice, M. Gulati, S. N. Dwivedi, and A. C. Ammini
Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2756 - 2762.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Skrha, T. Haas, G. Sindelka, M. Prazny, J. Widimsky, D. Cibula, and S. Svacina
Comparison of the Insulin Action Parameters from Hyperinsulinemic Clamps with Homeostasis Model Assessment and QUICKI Indexes in Subjects with Different Endocrine Disorders
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 135 - 141.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P.-H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, M. Laville, and M. Pugeat
Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3626 - 3631.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society